The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Nafsika H. Georgopapadakou

MethylGene

Inc., 7220 Rue Frederick-Banting

Bureau 200

Canada

[email]@aol.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • MethylGene, Inc., 7220 Rue Frederick-Banting, Bureau 200, Canada. 2004 - 2007
  • Infectious Diseases, MethylGene, Montreal, Canada. 2004
  • NewBiotics, Inc., 4939 Directors Place, San Diego, USA. 2002
  • Antimicrobial Research, DuPont Pharmaceuticals, Experimental Station, E400/3456A, USA. 2000 - 2001
  • DuPont Pharmaceuticals Research Laboratories, Experimental Station, E400/3442, Rt 141 & Henry Clay Road, USA. 1998

References

  1. Discontinued drugs in 2005: anti-infectives. Georgopapadakou, N. Expert. Opin. Investig. Drugs (2007) [Pubmed]
  2. Superbugs and Superdrugs: a focus on antibacterials--6th annual SMi conference. Georgopapadakou, N. Expert. Opin. Emerg. Drugs (2004) [Pubmed]
  3. Beta-lactamase inhibitors: evolving compounds for evolving resistance targets. Georgopapadakou, N.H. Expert. Opin. Investig. Drugs (2004) [Pubmed]
  4. Antifungals targeted to protein modification: focus on protein N-myristoyltransferase. Georgopapadakou, N.H. Expert. Opin. Investig. Drugs (2002) [Pubmed]
  5. Infectious disease 2001: drug resistance, new drugs. Georgopapadakou, N.H. Drug Resist. Updat. (2002) [Pubmed]
  6. Update on antifungals targeted to the cell wall: focus on beta-1,3-glucan synthase inhibitors. Georgopapadakou, N.H. Expert. Opin. Investig. Drugs (2001) [Pubmed]
  7. Antifungals targeted to sphingolipid synthesis: focus on inositol phosphorylceramide synthase. Georgopapadakou, N.H. Expert. Opin. Investig. Drugs (2000) [Pubmed]
  8. Antifungals: mechanism of action and resistance, established and novel drugs. Georgopapadakou, N.H. Curr. Opin. Microbiol. (1998) [Pubmed]
  9. Fungal diagnostics, pathogenesis and chemotherapy symposia. Georgopapadakou, N.H. IDrugs (1998) [Pubmed]
 
WikiGenes - Universities